ETHNIC VARIATIONS IN ANTIDEPRESSANT RESPONSE

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 为了确定非裔美国人和高加索抑郁症患者的基因特征如何影响他们对研究药物Celexa的反应。Celexa是一种已知有助于改善人的情绪的药物，已被FDA批准用于治疗抑郁症。这项研究还将检查社会经济变量在决定疗程和治疗反应方面的影响，以及可能影响这两组人对抗抑郁药Celexa治疗反应的其他基因的影响。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To determine how the genetic profile of African American and Caucasian depressed patients influence their responses to the study medication celexa. Celexa is a medication that is known to help improve a person's mood and has been approved by the FDA to use in the treatment of depression. This study will also examine the influence of socioeconomic variables in determining the course and treatment response and the influence of other genes that may also affect the therapeutic response of these two groups to the antidepressant celexa